C**X
发帖数: 1331 | |
u******n
发帖数: 5727 | |
C**X
发帖数: 1331 | 3 14开始新一轮
【在 u******n 的大作中提到】
: 能去14吗，准备等着。。
|
c******f
发帖数: 264 | |
u******n
发帖数: 5727 | |
x******n
发帖数: 36 | 6 新一轮反弹吗？
[在 CPRX (不买高点) 的大作中提到：]
：14开始新一轮
：【 在 upendown (northensouth) 的大作中提到: 】
：........... |
C**X
发帖数: 1331 | |
O****N
发帖数: 1458 | |
x******n
发帖数: 36 | 9 快14啦，捞不捞？
[在 CPRX (不买高点) 的大作中提到：]
：别急，等14 |
l*****t
发帖数: 8319 | 10 没，哭死
【在 C**X 的大作中提到】
: 新机会来了
|
|
|
l*********t
发帖数: 1067 | 11 14 again, in for some? or wait for 12? |
s*******i
发帖数: 2386 | 12 嗯，要去12 了，飞奔的那种。
【在 l*********t 的大作中提到】
: 14 again, in for some? or wait for 12?
|
l********i
发帖数: 2503 | 13 今天为毛跌这么多？两个月的涨幅一天跌完，太狠了 |
O****N
发帖数: 1458 | 14
难道有人有内幕消息？
【在 l********i 的大作中提到】
: 今天为毛跌这么多？两个月的涨幅一天跌完，太狠了
|
d**********r
发帖数: 24123 | 15 From Bloomberg today
FLML developing Micropump for single dose of Sodiul oxybate to traet
narcolepsy; Jazz Pharma's Xyrem uses two doses of sodium oxybate Patent
trail and appeal board yesterday issued decision denying covered business
method patent review for 4 Xyrem patents covering restricted distribution ,
JPMorgan analyst Jessica Fye said in note She sees as incremental poistive
for Jazz, removes potential threat to Xyrem franchise
是这个？
【在 l********i 的大作中提到】
: 今天为毛跌这么多？两个月的涨幅一天跌完，太狠了
|
l********i
发帖数: 2503 | 16 U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
currently markets as Bloxiverz.
这是真正的消息。原来只有他们一家批准，其他的都得下市，现在竞争的来了
,
【在 d**********r 的大作中提到】
: From Bloomberg today
: FLML developing Micropump for single dose of Sodiul oxybate to traet
: narcolepsy; Jazz Pharma's Xyrem uses two doses of sodium oxybate Patent
: trail and appeal board yesterday issued decision denying covered business
: method patent review for 4 Xyrem patents covering restricted distribution ,
: JPMorgan analyst Jessica Fye said in note She sees as incremental poistive
: for Jazz, removes potential threat to Xyrem franchise
: 是这个？
|
d**********r
发帖数: 24123 | 17 原来如此！
【在 l********i 的大作中提到】
: U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
: Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
: currently markets as Bloxiverz.
: 这是真正的消息。原来只有他们一家批准，其他的都得下市，现在竞争的来了
:
: ,
|
x****9
发帖数: 2668 | 18 谢谢。。。龙老师
U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
Drug Applicati........
【在 l********i 的大作中提到】
: U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
: Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
: currently markets as Bloxiverz.
: 这是真正的消息。原来只有他们一家批准，其他的都得下市，现在竞争的来了
:
: ,
|
c******f
发帖数: 264 | 19 soga!
【在 l********i 的大作中提到】
: U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
: Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
: currently markets as Bloxiverz.
: 这是真正的消息。原来只有他们一家批准，其他的都得下市，现在竞争的来了
:
: ,
|
H********6
发帖数: 776 | |
N*****d
发帖数: 9872 | |
